Healthcare firm Lupin is set to declare its results for the third quarter of financial year 2012-13 on Thursday. Analysts on an average expect profit after tax of the company to grow by 27 percent year-on-year to Rs 299 crore in the quarter.
Revenues are seen going up by 26 percent to Rs 2,284 crore from Rs 1,819 crore during the same period.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to go up by 26 percent YoY to Rs 470 crore in the October-December quarter.
Operating profit margin is expected to be at 20.6 percent in the third quarter of FY13 as against 20.5 percent in a year ago period.
According to analysts, the US market could exceed expectations in the quarter due to launch of Tricor generic + Yasmin generic. Therefore, margins could come in at 22 percent and profit after tax at more than 35-40 percent.
Lupin launched Tricor generic in November 2012, which has a limited competition.
Company launched Yasmin generic an OC (oral contraceptive) during the third quarter (which has a US sales of USD 275 million). According to analysts, Lupin's total potential from this drug is USD 10 million in profit after tax.
Products' (which have limited competition) launches like Combivir, Geodon, Seroquel should contribute in the quarter, analysts add.
Topline will also be helped by more than 40 percent of growth in Japan on the back of the I’rom acquisition; growth in advanced markets (ex-Japan); over 20 percent growth in SME - Semi Regulated markets; and over 10 percent growth in domestic markets.
In second quarter of FY13, profit after tax of the company rose by 8.8 percent YoY to Rs 290 crore and revenues jumped by 30 percent YoY to Rs 2,301 crore.
Indian business increased 18 percent YoY to Rs 606 crore in the second quarter while US business grew by 20 percent & Japan by over 85 percent YoY (aided by l'rom). Also Read
ICICI Bank Q3: Analysts expect profit to grow 20% to Rs 2077 cr
PNB Q3: Analysts expect profit to fall 4% YoY to Rs 1102cr
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
